Abstract |
The effects of reducing stress on glucose metabolism in diabetics were evaluated in 20 patients with type 2 diabetes (10 of each sex) who were given an anxiolytic ( fludiazepam) for 12 weeks. Patients were tested 4 weeks before the start of anxiolytic treatment (A), immediately before the first dose (B), and before the end of the study period (C) using the State-Trait Anxiety Index and glycosylated haemoglobin levels. There were no significant differences between the trait or state anxiety scores or the glycosylated haemoglobin levels at times A and B before treatment. However, for all three measurements, the values at time C, after treatment, showed significant improvements, compared with those at both times A and B (P < 0.05). The improvement in the trait anxiety score was weakly correlated with the decrease in the glycosylated haemoglobin level (r = 0.426, P < 0.01). No correlation was seen between state anxiety scores and glycosylated haemoglobin levels. The results suggest that suppressing anxiety in patients with type 2 diabetes reduces glycosylated haemoglobin levels.
|
Authors | S Okada, K Ichiki, S Tanokuchi, K Ishii, H Hamada, Z Ota |
Journal | The Journal of international medical research
(J Int Med Res)
1995 Mar-Apr
Vol. 23
Issue 2
Pg. 119-22
ISSN: 0300-0605 [Print] England |
PMID | 7601294
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Anti-Anxiety Agents
- Glycated Hemoglobin A
- Benzodiazepines
- fludiazepam
- Diazepam
|
Topics |
- Adult
- Aged
- Anti-Anxiety Agents
(therapeutic use)
- Anxiety
(blood, diagnosis, drug therapy)
- Benzodiazepines
- Diabetes Mellitus, Type 2
(blood, complications)
- Diazepam
(analogs & derivatives, therapeutic use)
- Female
- Glycated Hemoglobin
(metabolism)
- Humans
- Male
- Middle Aged
- Predictive Value of Tests
- Psychological Tests
- Stress, Psychological
(blood, complications, drug therapy)
- Treatment Outcome
|